Drug Shortage Report for AMERGE

Last updated on 2018-05-10 History
Report ID 30577
Drug Identification Number 02237820
Brand name AMERGE
Common or Proper name naratriptan hydrochloride tablets
Company Name GLAXOSMITHKLINE INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) NARATRIPTAN
Strength(s) 1MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 2's
ATC code N02CC
ATC description ANTIMIGRAINE PREPARATIONS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2018-01-04
Estimated end date 2018-05-09
Actual end date 2018-05-09
Shortage status Resolved
Updated date 2018-05-10
Company comments
Health Canada comments
Tier 3 Status No
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v18 2018-05-10 English Compare
v17 2018-05-09 French Compare
v16 2018-05-09 English Compare
v15 2018-05-02 French Compare
v14 2018-05-02 English Compare
v13 2018-03-14 French Compare
v12 2018-03-14 English Compare
v11 2018-02-21 French Compare
v10 2018-02-21 English Compare
v9 2018-01-05 English Compare
v8 2018-01-04 French Compare
v7 2018-01-04 English Compare
v6 2017-12-20 French Compare
v5 2017-12-20 English Compare
v4 2017-12-13 French Compare
v3 2017-12-13 English Compare
v2 2017-11-24 French Compare
v1 2017-11-24 English Compare

Showing 1 to 18 of 18